Clinical Trials on Atopic Dermatitis in United Kingdom

Total 1860 results

Imperial College London
JP Moulton Charitable Foundation

Recruiting

TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

Atopic Dermatitis Eczema

United Kingdom
Momentum Data
Pfizer; Royal College of General Practitioners Research and Surveillance Centre

Unknown

Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema

United Kingdom
University College, London
Dermatrust

Withdrawn

Investigating Immune Mechanisms in Atopic Eczema

Atopic Dermatitis

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; Sheffield Children's NHS Foundation Trust

Recruiting

Skin Pathology Assessment With Optical Technologies (SPOT)

Atopic Dermatitis Eczema

United Kingdom
Guy's and St Thomas' NHS Foundation Trust
King's College London; National Institute for Health Research, United Kingdom

Completed

Role of Anti-IgE in Severe Childhood Eczema (ADAPT)

Child | Atopic Dermatitis | Atopic Eczema

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Completed

Skin bioMARkers for Atopic Eczema Therapy Evaluation (SMART)

Atopic Eczema/Dermatitis (Non-Specific)

United Kingdom
Kari Nadeau
King's College London; National Institute of Allergy and Infectious Diseases... and other collaborators

Recruiting

Seal, Stopping Eczema and Allergy Study

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Eczema, Infantile

United States, United Kingdom
Atopix Therapeutics, Ltd.

Completed

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United Kingdom
Bristol-Myers Squibb

Completed

A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis

Healthy Subjects and Atopic Dermatitis Subjects

United Kingdom
LEO Pharma

Completed

LEO 29102 Single and Multiple Dose Study by Dermal Application

Atopic Dermatitis

United Kingdom
BenevolentAI Bio

Completed

A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United Kingdom
Astellas Pharma Europe B.V.

Completed

Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

United Kingdom
ACO Hud Nordic AB
The University of Sheffield Medical School

Completed

A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier

Dermatitis, Atopic

United Kingdom
AnaMar AB
Covance

Completed

A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis

Atopic Dermatitis

United Kingdom
LEO Pharma

Completed

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Atopic Dermatitis

United Kingdom
Ziarco Pharma Ltd

Completed

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

Atopic Dermatitis

United Kingdom
Sanofi
Regeneron Pharmaceuticals

Recruiting

A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis (PELISTAD-EX2)

Dermatitis Atopic

United States, United Kingdom
Sanofi
Regeneron Pharmaceuticals

Completed

Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis (PELISTAD)

Dermatitis Atopic

United States, United Kingdom
Royal Victoria Infirmary
British Skin Foundation

Completed

Narrowband UVB for Children With Moderate to Severe Atopic Eczema

Moderate to Severe Atopic Eczema

United Kingdom
LEO Pharma

Completed

Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102

Atopic Dermatitis

United Kingdom
University of Dundee
NHS Tayside

Completed

Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema

Atopic Eczema

United Kingdom
Creabilis SA

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

Atopic Dermatitis

United Kingdom
LEO Pharma

Completed

Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

Atopic Dermatitis

United Kingdom
Bayer

Completed

In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control

Atopic Dermatitis

United Kingdom
King's College London
University of Nottingham; Imperial College London; University of Sheffield; Guy... and other collaborators

Unknown

Softened Water for Eczema Prevention Pilot Trial (SOFTER)

Atopic Eczema

United Kingdom
Aerovance, Inc.

Completed

A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema

Atopic Eczema

United Kingdom
Ace Cells Lab Limited

Unknown

Revitalization of Damaged Skin Due to Chronic Skin Diseases

Psoriasis | Atopic Dermatitis | Chronic Eczema

Serbia, United Kingdom
LEO Pharma

Completed

LEO19123 Cream in the Treatment of Atopic Dermatitis

Atopic Dermatitis

United Kingdom, Finland, Canada, Denmark
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Active, not recruiting

A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study (STAR)

Atopic Eczema

United Kingdom
Evelo Biosciences, Inc.

Completed

A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Psoriasis | Atopic Dermatitis

United Kingdom
University of California, San Francisco
Sanofi; Regeneron Pharmaceuticals

Recruiting

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related Conditions

United States
Maruho Co., Ltd.

Completed

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Atopic Dermatitis

France, Germany, Poland, United Kingdom
UCB Biopharma SRL

Active, not recruiting

A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Atopic Dermatitis

Bulgaria, Germany, Netherlands, United Kingdom
Evelo Biosciences, Inc.

Completed

A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Psoriasis | Atopic Dermatitis

United Kingdom
Shaperon

Recruiting

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis of Scalp

United States
Amgen

Recruiting

A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants

Atopic Dermatitis

United States, United Kingdom
Dermal Laboratories Ltd

Recruiting

A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.

Atopic Eczema

United Kingdom
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (AQUA)

Dermatitis Atopic

United States, Chile, Canada, United Kingdom
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Completed

Atopic Dermatitis (AD) and Food Allergy

Atopic Dermatitis (AD) | Non-atopic Healthy Controls

United States
University of Southern California
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Active, not recruiting

Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis (TCH in AD)

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema

United States
National Jewish Health
Genentech, Inc.

Recruiting

Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum

Atopic Dermatitis With a History of Eczema Herpeticum | Atopic Dermatitis Without a History of Eczema Herpeticum | Health Controls Without Atopy

United States
Sanofi

Completed

A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries (AD-impaCT)

Dermatitis Atopic

Saudi Arabia, Kuwait, United Arab Emirates
LEO Pharma

Active, not recruiting

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)

Atopic Dermatitis

Spain, United Kingdom, Czechia, France, Netherlands
Galapagos NV

Terminated

A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis

Healthy | Atopic Dermatitis

Spain, Germany, Ukraine, United Kingdom
University of California, Irvine
Pfizer

Completed

Characterizing Skin Microbiome Change in Atopic Dermatitis

Atopic Dermatitis | Atopic Dermatitis Eczema

United States
University of California, San Diego

Completed

Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients

Atopic Dermatitis Eczema

United States
AOBiome LLC

Completed

Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.

Atopic Dermatitis Eczema

United States
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)

Atopic Dermatitis (AD)

United States, Canada
Ziarco Pharma Ltd

Completed

A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

Atopic Dermatitis

Belgium, Germany, Poland, United Kingdom
AKARI Therapeutics

Terminated

Topical rVA576 for Treatment of Atopic Keratoconjunctivitis

Atopic Keratoconjunctivitis (AKC)

United Kingdom

Clinical Trials on Atopic Dermatitis in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations